þ
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
Nevada
|
88-0313393
|
(State
or other jurisdiction of incorporation
or organization)
|
(IRS
Employer Identification No.)
|
20382
BARENTS SEA CIRCLE, LAKE FOREST, CA
|
92630
|
(Address
of principal executive offices)
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (949)
470-2300
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
(Do
not check if a smaller reporting company)
|
Smaller
reporting company þ
|
Page
|
|||
PART
I.
|
FINANCIAL
INFORMATION
|
4
|
|
ITEM
1.
|
Financial
Statements
|
4
|
|
Consolidated
Balance Sheets at June 30, 2009 (Unaudited) (Restated) and March 31, 2009
|
4
|
||
Unaudited
Consolidated Statements of Operations for the three months ended June 30,
2009 (Restated) and 2008
|
5
|
||
Unaudited
Consolidated Statements of Cash Flows for the three months ended June 30,
2009 (Restated) and 2008
|
6
|
||
Notes
to Consolidated Financial Statements ( Unaudited and
Restated )
|
8
|
||
ITEM
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
31
|
|
ITEM
4T:
|
Controls
and Procedures
|
40
|
|
PART
II
|
OTHER
INFORMATION
|
41
|
|
ITEM
1.
|
Legal
Proceedings
|
41
|
|
ITEM
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
41
|
|
ITEM
3.
|
Defaults
Upon Senior Securities
|
41
|
|
ITEM
4.
|
Submission
of Matters to a Vote of Security Holders
|
41
|
|
ITEM
5.
|
Other
Information
|
41
|
|
ITEM
6.
|
Exhibits
|
42
|
|
SIGNATURES
|
43
|
June
30,
|
March
31,
|
|||||||
2009
|
2009
|
|||||||
ASSETS
|
(unaudited)
|
|||||||
(restated)
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$
|
556,922
|
$
|
249,758
|
||||
Restricted
cash
|
101,650
|
101,053
|
||||||
Accounts
receivable, net
|
7,555
|
2,546
|
||||||
Inventories
|
512,556
|
530,241
|
||||||
Prepaid
expenses and other current assets
|
166,749
|
170,399
|
||||||
Total
current assets
|
1,345,432
|
1,053,997
|
||||||
Fixed
assets, net
|
180,922
|
189,301
|
||||||
Intangible
assets, net
|
268,230
|
264,364
|
||||||
Deferred
financing costs, net
|
51,286
|
3,600
|
||||||
Other
assets
|
30,367
|
61,294
|
||||||
$
|
1,876,237
|
$
|
1,572,556
|
|||||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$
|
321,326
|
$
|
218,433
|
||||
Accrued
expenses
|
90,640
|
90,547
|
||||||
Accrued
warranty costs
|
18,743
|
18,743
|
||||||
Accrued
salaries and related
|
221,108
|
206,180
|
||||||
Convertible
notes payable and accrued interest, net of discount of $754,486 at June
30, 2009 and $13,586 at March 31, 2009
|
242,552
|
46,414
|
||||||
Current
portion of convertible notes payable and accrued interest, net of discount
of $2,801,108 at June 30, 2009 and $662,583 at March 31,
2009
|
2,707,747
|
3,836,385
|
||||||
Line
of credit and accrued interest
|
90,300
|
90,310
|
||||||
Current
portion of related party notes payable
|
150,000
|
150,000
|
||||||
Current
portion of note payable to former officer
|
108,000
|
90,000
|
||||||
Liability
for derivative instruments
|
13,664,537
|
-
|
||||||
Total
current liabilities
|
17,614,953
|
4,747,012
|
||||||
Related
party notes payable and accrued interest, net of current
portion
|
1,520,554
|
1,533,760
|
||||||
Note
payable to former officer and accrued interest, net of current
portion
|
52,064
|
67,688
|
||||||
Convertible
notes payable, net of current portion and discount of $5,968,629 at June
30, 2009 and $6,681,629 at March 31, 2009
|
-
|
-
|
||||||
Total
liabilities
|
19,187,571
|
6,348,460
|
||||||
Stockholders’
deficit:
|
||||||||
Common
stock, $0.001 par value; 125,000,000 shares authorized; 43,913,830 at June
30, 2009 and 41,861,941 at March 31, 2009 shares issued and
outstanding
|
43,
914
|
41,863
|
||||||
Additional
paid-in capital
|
23,286,723
|
25,816,588
|
||||||
Accumulated
deficit
|
(40,641,971
|
)
|
(30,634,355
|
)
|
||||
Total
stockholders’ deficit
|
(17,311,334
|
)
|
(4,775,904
|
)
|
||||
$
|
1,876,237
|
$
|
1,572,556
|
For
The Three Months Ended
June
30,
|
||||||||
2009
|
2008
|
|||||||
(restated) | ||||||||
Net
sales
|
$
|
13,703
|
$
|
13,424
|
||||
Cost
of sales
|
149,177
|
118,378
|
||||||
Gross
loss
|
(135,474
|
)
|
(104,954
|
)
|
||||
Operating
expenses:
|
||||||||
Selling,
general and administrative expenses
|
728,309
|
560,040
|
||||||
Research
and development expenses
|
87,725
|
110,791
|
||||||
Total
operating expenses
|
816,034
|
670,831
|
||||||
Loss
from operations
|
(951,508
|
)
|
(775,785
|
)
|
||||
Other
income (expense):
|
||||||||
Interest
income
|
1,481
|
12,814
|
||||||
Interest
expense
|
(2,533,197
|
)
|
(555,769
|
)
|
||||
Loss
on sale of fixed assets
|
(797
|
)
|
-
|
|||||
Change
in fair value of derivative liabilities
|
3,134,298
|
-
|
||||||
Loss
on extinguishment of debt
|
-
|
(6,902,941
|
)
|
|||||
Total
other income (expense), net
|
601,785
|
(7,445,896
|
)
|
|||||
Loss
before income taxes
|
(349,723)
|
(8,221,681
|
)
|
|||||
Income
taxes
|
-
|
800
|
||||||
Net
loss
|
$
|
(349,723)
|
$
|
(8,222,481
|
)
|
|||
Net
loss per common share:
|
||||||||
Basic
and diluted
|
$
|
(0.01)
|
$
|
(0.20
|
)
|
|||
Weighted
average common shares outstanding:
|
||||||||
Basic
and diluted
|
42,939,649
|
41,018,074
|
For
The Three Months Ended
June
30,
|
||||||||
2009
|
2008
|
|||||||
(restated)
|
||||||||
Cash
flows from operating activities:
|
||||||||
Net
loss
|
$
|
(349,723)
|
$
|
(8,222,481
|
)
|
|||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
31,502
|
14,631
|
||||||
Amortization
of deferred financing costs
|
7,904
|
17,162
|
||||||
Amortization
of debt discount
|
2,268,690
|
418,275
|
||||||
Stock
issued to consultants
|
106,807
|
28,500
|
||||||
Fair
value of stock options and warrants issued to consultants, employees and
directors
|
272,312
|
53,887
|
||||||
Change
in fair value of derivative instrument
|
(3,134,298)
|
-
|
||||||
Loss
on extinguishment of debt
|
-
|
6,902,941
|
||||||
Loss
on sale of assets
|
797
|
-
|
||||||
Interest
earned on restricted cash
|
(597
|
)
|
(2,250
|
)
|
||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
receivable
|
(5,009
|
)
|
19,360
|
|||||
Inventories
|
17,685
|
(73,084
|
)
|
|||||
Prepaid
expenses and other assets
|
3,650
|
29,001
|
||||||
Accounts
payable
|
102,893
|
1,561
|
||||||
Accrued
expenses
|
93
|
9,398
|
||||||
Accrued
warranty costs
|
-
|
(5,625
|
)
|
|||||
Accrued
salaries and related
|
14,928
|
(4,354
|
)
|
|||||
Accrued
interest
|
156,406
|
118,164
|
||||||
Net
cash used in operating activities
|
(505,960
|
)
|
(694,914
|
)
|
||||
Cash
flows from investing activities:
|
||||||||
Payment
of trademark costs
|
(18,020
|
)
|
(633
|
)
|
||||
Purchases
of fixed assets
|
(9,766
|
)
|
(29,499
|
)
|
||||
Net
cash used in investing activities
|
(27,786
|
)
|
(30,132
|
)
|
||||
Cash
flows from financing activities:
|
||||||||
Net
proceeds from borrowings under convertible notes
|
926,500
|
1,062,500
|
||||||
Repayment
of convertible notes
|
-
|
(117,720
|
)
|
|||||
Repayment
of borrowings on line of credit, net
|
-
|
(12,500
|
)
|
|||||
Payment
of deferred financing costs
|
(55,590
|
)
|
(191,875
|
)
|
||||
Repayment
of note payable
|
-
|
(12,000
|
)
|
|||||
Repayments
of related party notes payable
|
(30,000
|
)
|
(30,000
|
)
|
||||
Repayments
of note payable to officer
|
-
|
(18,000
|
)
|
|||||
Proceeds
from exercise of options and warrants
|
-
|
3,308
|
||||||
Net
cash provided by financing activities
|
840,910
|
683,713
|
||||||
Net
change in cash and cash equivalents
|
307,164
|
(41,333
|
)
|
|||||
Cash
and cash equivalents, beginning of period
|
249,758
|
2,231,031
|
||||||
Cash
and cash equivalents, end of period
|
$
|
556,922
|
$
|
2,189,698
|
For
The Three Months Ended
June
30,
|
||||||||
2009
|
2008
|
|||||||
(restated)
|
||||||||
Supplemental
disclosure of cash flow information:
|
||||||||
Cash
paid during the year for:
|
||||||||
Interest
|
$
|
1,976
|
$
|
5,620
|
||||
Income
taxes
|
$
|
-
|
$
|
800
|
||||
Supplemental
disclosure of non-cash activities:
|
||||||||
Estimated
fair value of common stock and warrants granted in connection with
consulting agreement
|
$
|
-
|
$
|
28,500
|
||||
Deferred
financing costs in connection with convertible debt
financing
|
$
|
-
|
$
|
84,202
|
||||
Debt
discount in connection with convertible debt
financing
|
$
|
823,209
|
$
|
1,250,000
|
||||
Conversion
of debt and accrued interest to common stock
|
$
|
846,632
|
$
|
5,446
|
||||
Cashless
exercise of warrants
|
$
|
110
|
$
|
150
|
||||
Cancellation
of shares issued for debt principal reductions
|
$
|
-
|
$
|
117,720
|
||||
Estimated
fair value of warrants issued in connection with debt
modification
|
$
|
-
|
$
|
5,858,344
|
||||
Cumulative
effect of accounting change to debt discount for derivative
liabilities
|
$
|
2,595,095
|
$
|
-
|
||||
Cumulative
effect of accounting change to accumulated deficit for derivative
liabilities
|
$
|
9,657,893
|
$
|
-
|
||||
Cumulative
effect of accounting change to additional paid-in capital for derivative
liabilities
|
$
|
4,217,730
|
$
|
-
|
||||
Estimated
fair value of debt-related derivative liabilities reclassified from
liabilities to additional paid-in capital
|
$
|
593,303
|
$
|
As
Originally Filed
|
Restated
|
|||||||
Consolidated
Balance Sheet
|
||||||||
Current
portion of convertible notes payable and accrued interest, net of discount
of $3,514,107 (as originally filed) and $2,801,108
(restated)
|
1,994,748 | 2,707,747 | ||||||
Total
current liabilities
|
16,901,954 | 17,614,953 | ||||||
Total
liabilities
|
18,474,572 | 19,187,571 | ||||||
Accumulated
deficit
|
(39,928,972 | ) | (40,641,971 | ) | ||||
Total
stockholders’ deficit
|
(16,598,335 | ) | (17,311,334 | ) | ||||
Consolidated
Statement of Operations
|
||||||||
Interest
expense
|
(1,820,198 | ) | (2,533,197 | ) | ||||
Total
other income
|
1,314,784 | 601,785 | ||||||
Income
(loss) before income taxes
|
363,276 | (349,723 | ) | |||||
Net
income (loss)
|
363,276 | (349,723 | ) | |||||
Net
income (loss) per common share
|
||||||||
Basic
|
0.01 | (0.01 | ) | |||||
Diluted
|
0.01 | (0.01 | ) | |||||
Weighted
average common shares outstanding:
|
||||||||
Diluted
|
46,563,395 | 42,939,649 | ||||||
Consolidated
Statement of Cash flows
|
||||||||
Cash
flows from operating activities
|
||||||||
Net
income (loss)
|
363,276 | (349,723 | ) | |||||
Amortization
of debt discount
|
1,555,691 | 2,268,690 |
Furniture
and fixtures
|
7
years
|
Machinery
and equipment
|
5-7
years
|
Leasehold
improvements
|
Lesser
of lease term or estimated useful
life
|
2009
|
2008
|
|||||||
Beginning
warranty accrual
|
$
|
18,743
|
$
|
29,993
|
||||
Increase
in accrual (charged to cost of sales)
|
-
|
750
|
||||||
Charges
to accrual (product replacements)
|
-
|
(12,000
|
)
|
|||||
Ending
warranty accrual
|
$
|
18,743
|
$
|
18,743
|
June
30,
|
June
30,
|
||||
2009
|
2008
|
||||
Stock
warrants:
|
|||||
Expected
term
|
5
years
|
5
years
|
|||
Expected
volatility
|
197%
|
218%
|
|||
Risk-free
interest rate
|
1.86%
- 2.71%
|
2.84%-3.15%
|
|||
Expected
dividends
|
N/A
|
N/A
|
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average Remaining Contractual Term (Yrs.)
|
Aggregate
Intrinsic Value
|
|||||||||||||
Outstanding
at March 31, 2009
|
5,233,880
|
$
|
0.69
|
|||||||||||||
Granted
|
210,000
|
$
|
0.56
|
|||||||||||||
Exercised
|
(110,345
|
)
|
$
|
0.04
|
||||||||||||
Forfeited
|
(8,655
|
)
|
$
|
0.04
|
||||||||||||
Outstanding
and expected to vest at June 30, 2009
|
5,324,880
|
$
|
0.70
|
6.83
|
$
|
118,637
|
||||||||||
Exercisable
at June 30, 2009
|
4,774,870
|
$
|
0.68
|
6.53
|
$
|
118,637
|
Three
Months Ended June 30,
|
||||||||
2009
|
2008
|
|||||||
(restated) | ||||||||
Numerator:
|
||||||||
Net
loss
|
$
|
(349,723)
|
$
|
(8,222,481
|
)
|
|||
Denominator:
|
||||||||
Weighted
average shares outstanding for basic and diluted net loss per
share
|
42,939,649
|
41,018,074
|
||||||
Basic
and diluted net loss per common share
|
$
|
(0.01)
|
$
|
(0.20
|
)
|
As
Previously Reported
|
As
Adjusted
|
Cumulative
Adjustment
|
||||||||||
Liabilities
and Stockholders’ Deficit:
|
||||||||||||
Total
liabilities
|
$
|
6,348,460
|
$
|
20,224,083
|
$
|
13,875,623
|
||||||
Stockholders’
deficit:
|
||||||||||||
Common
stock
|
41,863
|
41,863
|
—
|
|||||||||
Additional
paid-in capital
|
25,816,588
|
21,598,858
|
(4,217,730
|
)
|
||||||||
Accumulated
deficit
|
(30,634,355
|
)
|
(40,292,248
|
)
|
(9,657,893
|
)
|
||||||
Total
stockholders’ deficit
|
(4,775,904
|
)
|
(18,651,527
|
)
|
(13,875,623
|
)
|
||||||
Total
liabilities and stockholders’ deficit
|
$
|
1,572,556
|
$
|
1,572,556
|
$
|
—
|
June
30,
|
March
31,
|
|||||||
2009
|
2009
|
|||||||
(unaudited)
|
||||||||
Raw
materials
|
$
|
358,789
|
$
|
350,021
|
||||
Work
in process
|
6,988
|
7,253
|
||||||
Finished
goods
|
146,779
|
172,967
|
||||||
$
|
512,556
|
$
|
530,241
|
June
30,
|
March
31,
|
|||||||
2009
|
2009
|
|||||||
(unaudited)
|
||||||||
Furniture
and fixtures
|
$
|
23,253
|
$
|
23,253
|
||||
Machinery
and equipment
|
649,717
|
640,748
|
||||||
Leasehold
improvements
|
19,426
|
19,426
|
||||||
692,396
|
683,427
|
|||||||
Less
accumulated depreciation and
amortization
|
(511,474
|
)
|
(494,126
|
)
|
||||
$
|
180,922
|
$
|
189,301
|
June
30,
2009
|
March
31,
2009
|
|||||||
(unaudited)
|
||||||||
Patents
and trademarks
|
$
|
65,395
|
$
|
47,375
|
||||
Software
|
282,112
|
282,112
|
||||||
347,507
|
329,487
|
|||||||
Less
accumulated amortization
|
(79,277
|
)
|
(65,123
|
)
|
||||
$
|
268,230
|
$
|
264,364
|
June
30,
2009
|
March
31,
2009
|
|||||||
(unaudited)
|
||||||||
(restated) | ||||||||
October
2007 Debentures
|
$
|
4,643,073
|
$
|
5,356,073
|
||||
May
2008 Debentures
|
1,325,556
|
1,325,556
|
||||||
March
and May 2009 Private Placement Debentures
|
986,500
|
60,000
|
||||||
Accrued
interest on convertible debentures
|
48,158
|
44,544
|
||||||
7,003,287
|
6,786,173
|
|||||||
Debt
discount
|
(4,052,988
|
)
|
(2,903,374
|
)
|
||||
Total
convertible debentures, net
|
$
|
2,950,299
|
3,882,799
|
|||||
Convertible
notes payable and accrued interest, net
|
$
|
242,552
|
$
|
46,414
|
||||
Current
portion of convertible notes payable, net
|
2,707,747
|
3,836,385
|
||||||
Convertible
notes payable, net
|
$
|
2,950,299
|
$
|
3,882,799
|
June
30,
|
April
1,
|
|||||||
2009
|
2009
|
|||||||
Annual
dividend yield
|
—
|
—
|
||||||
Expected
life (years)
|
4.51
– 5.00
|
3.50
– 5.00
|
||||||
Risk-free
interest rate
|
1.65%
|
1.65%
|
||||||
Expected
volatility
|
197%
|
204%
|
Level
3
|
Level
3
|
|||||||
Carrying
Value
|
Carrying
Value
|
|||||||
June
30, 2009
|
April
1, 2009
|
|||||||
(unaudited)
|
(unaudited)
|
|||||||
Embedded
Conversion Option
|
$
|
2,929,506
|
$
|
3,900,134
|
||||
Warrants
|
10,735,031
|
12,570,584
|
||||||
$
|
13,664,537
|
$
|
16,470,718
|
|||||
Decrease
in fair value included in other income
|
$
|
3,134,298
|
Balance
at March 31, 2009
|
$
|
—
|
||
Cumulative
effect of EITF 07-5
|
16,470,718
|
|||
Issuance
of warrants
|
317,140
|
|||
Issuance
of convertible notes
|
604,280
|
|||
Conversions
of notes
|
(593,303)
|
|||
Change
in fair value included in other income
|
(3,134,298
|
)
|
||
Balance
at June 30, 2009
|
$
|
13,664,537
|
●
|
THE
SUCCESS OR FAILURE OF MANAGEMENT’S EFFORTS TO IMPLEMENT THE COMPANY’S PLAN
OF OPERATIONS;
|
●
|
THE
COMPANY’S ABILITY TO FUND ITS OPERATING EXPENSES;
|
●
|
THE
COMPANY’S ABILITY TO COMPETE WITH OTHER COMPANIES THAT HAVE A SIMILAR PLAN
OF OPERATION;
|
●
|
THE
EFFECT OF CHANGING ECONOMIC CONDITIONS IMPACTING THE COMPANY’S PLAN OF
OPERATION; AND
|
●
|
THE
COMPANY’S ABILITY TO MEET THE OTHER RISKS AS MAY BE DESCRIBED IN ITS
FUTURE FILINGS WITH THE SECURITIES AND EXCHANGE
COMMISSION.
|
1)
|
Focusing
additional effort on the commercialization of the CryoPort Express™
System. Management has begun initiating meetings with potential customers
for the use of the CryoPort
Express.
|
2)
|
Aggressively
seeking additional capital sources for significant long-term funding of
approximately $10,000,000 to allow the Company to fully commercialize the
CryoPort Express™ System and to achieve and sustain profitable
operations.
|
3)
|
Pursue
and complete a strategic partnership with large freight carriers to be
able to provide a one call simple and reliable solution to shipping frozen
samples. The partnership will also facilitate the ability of
the Company to rapidly call on and achieve sales with the largest target
customers.
|
4)
|
Minimizing
operating and financing expenditures through stringent cost containment
measures to ensure the availability of funds until additional funding is
secured, then continue to minimize expenditures until sufficient revenues
are generated and cash collections adequately support the continued
business operations. The Company’s largest expenses for the
three months ended June 30, 2009, relate to non-cash expenses
including (i) $ 2,268,690 non-cash expense
included in interest expense relating to the amortization of discounts on
convertible debentures and (ii) non-cash expense recorded in selling,
general and administrative costs of $379,119 related to the valuations of
common stock shares and warrants issued in lieu of cash for consulting
services as well as for directors’ and employee
compensation. For the three months ended June 30, 2009, the
Company also incurred cash expenses of (i) approximately $69,000 for the
audit fees and consulting services related to the filing of the Company’s
annual and quarterly reports and compliance with the Sarbanes-Oxley
requirements and (ii) approximately $19,000 additional research and
development costs related to the development of the web based system to be
used as a vital function of the CryoPort Express™ System. The
remaining operating expenses for the quarter ended June 30, 2009 related
primarily to minimal overhead costs including personnel costs, rent and
utilities and meeting the legal and reporting requirements of a public
company.
|
5)
|
Utilizing
part-time consultants and temporary employees and requiring employees to
manage multiple roles and responsibilities whenever possible as the
Company has historically utilized in its efforts to keep operating
expenditures minimized.
|
6)
|
Continuing
to require that key employees and the Company’s Board of Directors receive
Company stock in lieu of cash as a portion of their compensation in an
effort to minimize cash expenditures. With this strategy, the Company has
established a team of experienced business professionals for advancing and
launching the Company’s products.
|
7)
|
Maintaining
basic levels for sales, engineering, and operating personnel and gradually
adding critical key personnel only as affordable and necessary to support
the expected revenue growth of the CryoPort Express™ System and any
further expansion of the Company’s product offerings in the reusable and
frozen shipping markets.
|
8)
|
Adding
other expenses such as customer service, administrative and operations
staff only when commensurate with producing increased
revenues.
|
9)
|
Focusing
current research and development efforts only on final and future
development, production and distribution of the CryoPort Express™
System.
|
10)
|
Increasing
sales efforts to focus on the bio-pharmaceutical, clinical trials and
cold-chain distribution industries in order to identify and call on the
top potential customers for the CryoPort Express™
System.
|
10.1
|
Investment
Banker Termination Agreement, dated April 6, 2009, by and among the
Company, Bradley Wood & Co., Ltd., SEPA Capital Corp. and Edward Fine.
Incorporated by reference to the Company’s Registration Statement on Form
S-8 filed on April 13, 2009.
|
31.1
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Executive
Officer
|
31.2
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Financial
Officer
|
32.1
|
Certification
Pursuant to 18 U.S.C. §1350 of Chief Executive Officer
|
32.2 |
Certification
Pursuant to 18 U.S.C. §1350 of Chief Financial Officer
|
CryoPort,
Inc.
|
|||
By: | /s/ Larry G. Stambaugh | ||
Larry
G. Stambaugh, Chairman,
Chief Executive Officer
|
|||
Dated:
November 2 , 2009
|
By:
|
/s/
Catherine M. Doll
|
|
Catherine
M. Doll, Chief Financial Officer
(Principal Financial and Accounting Officer)
|